TWD 39.6
(-23.55%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 106.65 Million TWD | 2260.04% |
2022 | 4.51 Million TWD | -78.63% |
2021 | 21.14 Million TWD | 230722.96% |
2020 | 9162.00 TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 103.06 Million TWD | 0.0% |
2024 Q1 | 103.06 Million TWD | -3.36% |
2023 Q4 | 106.65 Million TWD | 0.0% |
2023 FY | 106.65 Million TWD | 2260.04% |
2023 Q3 | 106.65 Million TWD | 0.46% |
2023 Q2 | 106.15 Million TWD | 0.0% |
2023 Q1 | 106.15 Million TWD | 2249.17% |
2022 Q4 | 4.51 Million TWD | 0.0% |
2022 Q3 | 4.51 Million TWD | 0.0% |
2022 FY | 4.51 Million TWD | -78.63% |
2021 FY | 21.14 Million TWD | 230722.96% |
2020 FY | 9162.00 TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -1424.878% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 81.722% |
Level Biotechnology Inc. | 273.2 Million TWD | 60.963% |
Sagittarius Life Science Corp | 137.82 Million TWD | 22.619% |
NeoCore Technology Co., Ltd. | 197.47 Million TWD | 45.992% |
TaiMed Biologics Inc. | 1.32 Billion TWD | 91.968% |
GlycoNex Incorporation | 276.39 Million TWD | 61.414% |
VBI | 21.25 Million TWD | -401.859% |
GeneReach Biotechnology Corp. | 313.7 Million TWD | 66.003% |
Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 79.277% |
SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -402.45% |
Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 71.045% |
Visgeneer Inc. | 185.6 Million TWD | 42.539% |
Mycenax Biotech Inc. | 1.32 Billion TWD | 91.94% |
Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 85.45% |
G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 11.021% |
Neith Corporation | 17.43 Million TWD | -511.771% |
Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 95.252% |
TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -1511.514% |
Enimmune corporation | 173.46 Million TWD | 38.517% |
TaiRx, Inc. | 60.62 Million TWD | -75.918% |
CHO Pharma, Inc. | 110.83 Million TWD | 3.773% |
EirGenix Inc. | 1.14 Billion TWD | 90.686% |
BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 4.761% |
Sunny Pharmtech Inc. | 512.43 Million TWD | 79.188% |
Lin BioScience, Inc. | 167.73 Million TWD | 36.416% |
BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -13.804% |
Feng Chi Biotech Corp. | 63.03 Million TWD | -69.194% |
Bio Preventive Medicine Corp. | 124.72 Million TWD | 14.495% |
Lukas Biomedical Inc. | 161.05 Million TWD | 33.782% |
RBC Bioscience Corporation | 513.08 Million TWD | 79.214% |
BiOptic Inc. | 170.56 Million TWD | 37.472% |
BRIM Biotechnology, Inc. | 42.15 Million TWD | -152.977% |
Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -358.611% |
Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -297.755% |
Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 89.057% |
Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -1237.807% |
NaviFUS Corp. | 53.4 Million TWD | -99.715% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 77.85% |
Sinew Pharma Inc. | 39.71 Million TWD | -168.545% |
Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -83.756% |
Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 70.739% |
Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 53.161% |
Medigen Biotechnology Corp. | 3.53 Billion TWD | 96.979% |
3D Global Biotech Inc. | 30.68 Million TWD | -247.609% |
Pharmosa Biopharm Inc. | 195.99 Million TWD | 45.584% |
Intech Biopharm Corporation | 1.54 Billion TWD | 93.089% |
Oneness Biotech Co., Ltd. | 866.42 Million TWD | 87.691% |
Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -1049.741% |
TWi Biotechnology, Inc. | 55.81 Million TWD | -91.085% |
Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 54.219% |
TCI GENE Inc. | 155.54 Million TWD | 31.436% |
MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -318.104% |
Senhwa Biosciences, Inc. | 46.17 Million TWD | -130.969% |
Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 67.531% |
NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -64.363% |
PharmaEngine, Inc. | 91 Million TWD | -17.19% |
Savior Lifetec Corporation | 457.95 Million TWD | 76.712% |
TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 3.867% |
OBI Pharma, Inc. | 650.44 Million TWD | 83.604% |
Meribank Biotech Co., Ltd | 390.81 Million TWD | 72.711% |
Acepodia, Inc. | 384.47 Million TWD | 72.261% |
Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -24.66% |